Tam, Wayne
Mayo Clinic
Department of Pathology, Northwell Health, New York, NY, USA.
Citations 2
DNA mismatch repair defect and intratumor heterogeneous deficiency differently impact immune responses in diffuse large B-cell lymphoma
Xu‐Monette, Zijun Y. , Luo, Cancan, Li, Yong , Bhagat, Govind , Tzankov, Alexandar , Visco, Carlo, Fan, Xiangshan , Dybkær, Karen , Sakhdari, Ali , Wang, N, Yuan, Alyssa F. , Chiu, April , Tam, Wayne , Zu, Youli , Perry, Anamarija M. , O’Malley, Dennis P. , Au, Qingyan , Nunns, Harry , Parsons, Benjamin M. , Ferreri, Andrés J.M. , Sohani, Aliyah R. , Xu, Bing, Young, Ken H. , Li, Yong , Bhagat, Govind , Tzankov, Alexandar , Dybkaer, Karen , Sakhdari, Ali , Tam, Wayne , Zu, Youli , Hsi, Eric D , Go, Heounjeong , Møller, Michael Boe , Parsons, Benjamin M , Montes-Moreno, Santiago , Young, Ken H , Fan, Xiangshan , Xu-Monette, Zijun Y , Li, Yu , Visco, Carlo , Hsi, Eric D. , Song, Wenting , Go, Heounjeong , Møller, Michael , Montes‐Moreno, Santiago , Ponzoni, Maurilio , Abramson, Jeremy S.
OncoImmunology | August 5, 2024 | Volume: 13 | Issue: 1 | Pages: No page available
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML
Swords, Ronan , Maris, Michael B., Zeidner, Joshua F. , Foran, James M. , Cruz, José C. , Tam, Wayne , Vardhanabhuti, Saran , Pawlikowska-Dobler, Iwona , Faessel, Hélène M. , Dash, Ajeeta B. , Sedarati, Farhad , Dezube, Bruce J., Faller, Douglas V. , Swords, Ronan T , Zeidner, Joshua F , Cruz, Jose , Tam, Wayne , Vardhanabhuti, Saran , Pawlikowska-Dobler, Iwona , Dash, Ajeeta B , Sedarati, Farhad , Faller, Douglas V , Savona, Michael R , Coutré, Steven , Erba, Harry Paul , Berdeja, Jesús G. , Savona, Michael R.
Blood | January 18, 2018 | Volume: 131 | Issue: 13 | Pages: 1415-1424
Key Points RP2D of PEV 20 mg/m2 in PEV/AZA combo did not alter toxicity profile of AZA; dose-limiting toxicities were transiently elevated AST/ALT. In treatment-naive older AML patients, the intent-to-treat ORR was 50%.